Multiomics – News and Features

The agreement named CRADA is initiated to develop methods to detect DNA damage caused by ionizing radiation using BioNanomatrix’ whole genome analyzer.

Arrowhead to sponsor the continued research of Dr. Eric Davidson’s laboratory at the California Institute of Technology with $255,000 annually for three years.

New ChemAxon whitepaper discusses the drivers behind the increasing number of pharma and biotech companies moving from traditional proprietary chemical information systems to modern alternatives.

Cellzome has mined its proteomic database to investigate the physico-chemical principles governing mass spectrometric peptide sequencing.

The PersonalDV and the DeltaVision Core are set to enable high-resolution, high-throughput experimentation for research and drug discovery.

Proteus™ and Geneus™ lab and data management solutions selected by UK Genomics Facility and RASOR.

The Society for Biomolecular Sciences (SBS) presents renowned industry experts who will explore the future of drug discovery.

The consortium exploits experimental and computational methods to probe the biological mechanisms underlying industrial fermentation.

This research advances researchers’ understanding of how the cell nucleus is organized.

Extended partnership to focus on developing methods with the ProteomicProcessor™ for cancer biomarker detection.